123 related articles for article (PubMed ID: 17332315)
21. Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count.
Nguyen JT; Condron MR; Nguyen ND; De J; Medeiros LJ; Padula A
Pathol Int; 2009 May; 59(5):345-53. PubMed ID: 19432678
[TBL] [Abstract][Full Text] [Related]
22. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
[TBL] [Abstract][Full Text] [Related]
23. Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma.
Rassidakis GZ; Lai R; Herling M; Cromwell C; Schmitt-Graeff A; Medeiros LJ
Am J Pathol; 2004 Jun; 164(6):2259-67. PubMed ID: 15161658
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.
Amin HM; McDonnell TJ; Ma Y; Lin Q; Fujio Y; Kunisada K; Leventaki V; Das P; Rassidakis GZ; Cutler C; Medeiros LJ; Lai R
Oncogene; 2004 Jul; 23(32):5426-34. PubMed ID: 15184887
[TBL] [Abstract][Full Text] [Related]
25. TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells.
Rust R; Blokzijl T; Harms G; Lim M; Visser L; Kamps WA; Poppema S; van den Berg A
J Pathol; 2005 Aug; 206(4):445-50. PubMed ID: 15920698
[TBL] [Abstract][Full Text] [Related]
26. High-dose therapy and autologous stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK-negative anaplastic large-cell lymphoma.
Zamkoff KW; Matulis MD; Mehta AC; Beaty MW; Hutchison RE; Gentile TC
Bone Marrow Transplant; 2004 Mar; 33(6):635-8. PubMed ID: 15004538
[TBL] [Abstract][Full Text] [Related]
27. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
[TBL] [Abstract][Full Text] [Related]
28. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type.
Pileri SA; Pulford K; Mori S; Mason DY; Sabattini E; Roncador G; Piccioli M; Ceccarelli C; Piccaluga PP; Santini D; Leone O; Stein H; Falini B
Am J Pathol; 1997 Apr; 150(4):1207-11. PubMed ID: 9094977
[TBL] [Abstract][Full Text] [Related]
29. Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
Ait-Tahar K; Liggins AP; Collins GP; Campbell A; Barnardo M; Lawrie C; Moir D; Hatton C; Banham AH; Pulford K
Br J Haematol; 2009 Aug; 146(4):396-407. PubMed ID: 19552722
[TBL] [Abstract][Full Text] [Related]
30. Expression of ALK protein, mRNA and fusion transcripts in anaplastic large cell lymphoma.
Huang W; Li X; Yao X; Lu Y; Li B; Sheng W; Lu H; Jin A; Zhou X
Exp Mol Pathol; 2009 Apr; 86(2):121-6. PubMed ID: 19135051
[TBL] [Abstract][Full Text] [Related]
31. In vivo T-cell immune response against anaplastic lymphoma kinase in patients with anaplastic large cell lymphomas.
Passoni L; Gallo B; Biganzoli E; Stefanoni R; Massimino M; Di Nicola M; Gianni AM; Gambacorti-Passerini C
Haematologica; 2006 Jan; 91(1):48-55. PubMed ID: 16434370
[TBL] [Abstract][Full Text] [Related]
32. ALK-positive anaplastic large cell lymphoma in a patient with chronic lymphocytic leukemia.
Liu T; He M; Carlson DL; Hedvat C; Teruya-Feldstein J
Int J Surg Pathol; 2010 Oct; 18(5):424-8. PubMed ID: 18794171
[TBL] [Abstract][Full Text] [Related]
33. Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma: A report from the children's oncology group.
Nasr MR; Laver JH; Chang M; Hutchison RE
Am J Clin Pathol; 2007 May; 127(5):770-8. PubMed ID: 17439836
[TBL] [Abstract][Full Text] [Related]
34. CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.
Ait-Tahar K; Liggins AP; Collins GP; Campbell A; Barnardo M; Cabes M; Lawrie CH; Moir D; Hatton C; Banham AH; Pulford K
Haematologica; 2011 Jan; 96(1):78-86. PubMed ID: 20851862
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic large cell lymphoma: a flow cytometric analysis of 29 cases.
Kesler MV; Paranjape GS; Asplund SL; McKenna RW; Jamal S; Kroft SH
Am J Clin Pathol; 2007 Aug; 128(2):314-22. PubMed ID: 17638668
[TBL] [Abstract][Full Text] [Related]
36. Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.
Mussolin L; Damm-Welk C; Pillon M; Zimmermann M; Franceschetto G; Pulford K; Reiter A; Rosolen A; Woessmann W
Leukemia; 2013 Feb; 27(2):416-22. PubMed ID: 22907048
[TBL] [Abstract][Full Text] [Related]
37. Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Lin Q; Atwell C; Medeiros LJ; Amin HM
Hum Pathol; 2005 Sep; 36(9):939-44. PubMed ID: 16153455
[TBL] [Abstract][Full Text] [Related]
38. ALK positive lymphohistiocytic variant of anaplastic large cell lymphoma in an adult.
Paulli M; Vallisa D; Viglio A; Boveri E; Kindl S; Vassallo G; Magrini U; Cavanna L
Haematologica; 2001 Mar; 86(3):260-5. PubMed ID: 11255272
[TBL] [Abstract][Full Text] [Related]
39. Cytologic and immunocytochemical findings of anaplastic large cell lymphoma: analysis of ten fine-needle aspiration specimens over a 9-year period.
Ng WK; Ip P; Choy C; Collins RJ
Cancer; 2003 Feb; 99(1):33-43. PubMed ID: 12589644
[TBL] [Abstract][Full Text] [Related]
40. Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma.
Pulford K; Falini B; Banham AH; Codrington D; Roberton H; Hatton C; Mason DY
Blood; 2000 Aug; 96(4):1605-7. PubMed ID: 10942417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
